Global Adenosylcobalamin Tablets Market Growth 2026-2032
The global Adenosylcobalamin Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Adenosylcobalamin is a drug used to treat anemia and other related symptoms caused by vitamin B12 deficiency. Adenosylcobalamin is an active form of vitamin B12 and is essential for the body's hematopoietic function and the health of the nervous system.
United States market for Adenosylcobalamin Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Adenosylcobalamin Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Adenosylcobalamin Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Adenosylcobalamin Tablets players cover Hebei Bianque Pharmaceutical Co., Ltd., Fujian Gutian Pharmaceutical Co., Ltd., Shijiazhuang Kangli Pharmaceutical Co., Ltd., North China Pharmaceutical Co., Ltd., Sinopharm Group Rongsheng Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Adenosylcobalamin Tablets Industry Forecast” looks at past sales and reviews total world Adenosylcobalamin Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Adenosylcobalamin Tablets sales for 2026 through 2032. With Adenosylcobalamin Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adenosylcobalamin Tablets industry.
This Insight Report provides a comprehensive analysis of the global Adenosylcobalamin Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adenosylcobalamin Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adenosylcobalamin Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adenosylcobalamin Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adenosylcobalamin Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Adenosylcobalamin Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Adenosylcobalamin Tablets market?
What factors are driving Adenosylcobalamin Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Adenosylcobalamin Tablets market opportunities vary by end market size?
How does Adenosylcobalamin Tablets break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Adenosylcobalamin is a drug used to treat anemia and other related symptoms caused by vitamin B12 deficiency. Adenosylcobalamin is an active form of vitamin B12 and is essential for the body's hematopoietic function and the health of the nervous system.
United States market for Adenosylcobalamin Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Adenosylcobalamin Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Adenosylcobalamin Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Adenosylcobalamin Tablets players cover Hebei Bianque Pharmaceutical Co., Ltd., Fujian Gutian Pharmaceutical Co., Ltd., Shijiazhuang Kangli Pharmaceutical Co., Ltd., North China Pharmaceutical Co., Ltd., Sinopharm Group Rongsheng Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Adenosylcobalamin Tablets Industry Forecast” looks at past sales and reviews total world Adenosylcobalamin Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Adenosylcobalamin Tablets sales for 2026 through 2032. With Adenosylcobalamin Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adenosylcobalamin Tablets industry.
This Insight Report provides a comprehensive analysis of the global Adenosylcobalamin Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adenosylcobalamin Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adenosylcobalamin Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adenosylcobalamin Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adenosylcobalamin Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Adenosylcobalamin Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Boxed
- Bottled
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hebei Bianque Pharmaceutical Co., Ltd.
- Fujian Gutian Pharmaceutical Co., Ltd.
- Shijiazhuang Kangli Pharmaceutical Co., Ltd.
- North China Pharmaceutical Co., Ltd.
- Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
- North China Pharmaceutical Hebei Huanuo Co., Ltd.
- Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
- Ningxia Zhouyang Pharmaceutical Co., Ltd.
What is the 10-year outlook for the global Adenosylcobalamin Tablets market?
What factors are driving Adenosylcobalamin Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Adenosylcobalamin Tablets market opportunities vary by end market size?
How does Adenosylcobalamin Tablets break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adenosylcobalamin Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Adenosylcobalamin Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Adenosylcobalamin Tablets by Country/Region, 2021, 2025 & 2032
2.2 Adenosylcobalamin Tablets Segment by Type
2.2.1 Boxed
2.2.2 Bottled
2.2.3 Adenosylcobalamin Tablets Sales by Type
2.2.3.1 Global Adenosylcobalamin Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Adenosylcobalamin Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Adenosylcobalamin Tablets Sale Price by Type (2021-2026)
2.3 Adenosylcobalamin Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Adenosylcobalamin Tablets Sales by Application
2.3.4.1 Global Adenosylcobalamin Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Adenosylcobalamin Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Adenosylcobalamin Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Adenosylcobalamin Tablets Breakdown Data by Company
3.1.1 Global Adenosylcobalamin Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Adenosylcobalamin Tablets Sales Market Share by Company (2021-2026)
3.2 Global Adenosylcobalamin Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Adenosylcobalamin Tablets Revenue by Company (2021-2026)
3.2.2 Global Adenosylcobalamin Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Adenosylcobalamin Tablets Sale Price by Company
3.4 Key Manufacturers Adenosylcobalamin Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adenosylcobalamin Tablets Product Location Distribution
3.4.2 Players Adenosylcobalamin Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ADENOSYLCOBALAMIN TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Adenosylcobalamin Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Adenosylcobalamin Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Adenosylcobalamin Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Adenosylcobalamin Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Adenosylcobalamin Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Adenosylcobalamin Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Adenosylcobalamin Tablets Sales Growth
4.4 APAC Adenosylcobalamin Tablets Sales Growth
4.5 Europe Adenosylcobalamin Tablets Sales Growth
4.6 Middle East & Africa Adenosylcobalamin Tablets Sales Growth
5 AMERICAS
5.1 Americas Adenosylcobalamin Tablets Sales by Country
5.1.1 Americas Adenosylcobalamin Tablets Sales by Country (2021-2026)
5.1.2 Americas Adenosylcobalamin Tablets Revenue by Country (2021-2026)
5.2 Americas Adenosylcobalamin Tablets Sales by Type (2021-2026)
5.3 Americas Adenosylcobalamin Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adenosylcobalamin Tablets Sales by Region
6.1.1 APAC Adenosylcobalamin Tablets Sales by Region (2021-2026)
6.1.2 APAC Adenosylcobalamin Tablets Revenue by Region (2021-2026)
6.2 APAC Adenosylcobalamin Tablets Sales by Type (2021-2026)
6.3 APAC Adenosylcobalamin Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Adenosylcobalamin Tablets by Country
7.1.1 Europe Adenosylcobalamin Tablets Sales by Country (2021-2026)
7.1.2 Europe Adenosylcobalamin Tablets Revenue by Country (2021-2026)
7.2 Europe Adenosylcobalamin Tablets Sales by Type (2021-2026)
7.3 Europe Adenosylcobalamin Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adenosylcobalamin Tablets by Country
8.1.1 Middle East & Africa Adenosylcobalamin Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Adenosylcobalamin Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Adenosylcobalamin Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Adenosylcobalamin Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adenosylcobalamin Tablets
10.3 Manufacturing Process Analysis of Adenosylcobalamin Tablets
10.4 Industry Chain Structure of Adenosylcobalamin Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adenosylcobalamin Tablets Distributors
11.3 Adenosylcobalamin Tablets Customer
12 WORLD FORECAST REVIEW FOR ADENOSYLCOBALAMIN TABLETS BY GEOGRAPHIC REGION
12.1 Global Adenosylcobalamin Tablets Market Size Forecast by Region
12.1.1 Global Adenosylcobalamin Tablets Forecast by Region (2027-2032)
12.1.2 Global Adenosylcobalamin Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Adenosylcobalamin Tablets Forecast by Type (2027-2032)
12.7 Global Adenosylcobalamin Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hebei Bianque Pharmaceutical Co., Ltd.
13.1.1 Hebei Bianque Pharmaceutical Co., Ltd. Company Information
13.1.2 Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.1.3 Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hebei Bianque Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Hebei Bianque Pharmaceutical Co., Ltd. Latest Developments
13.2 Fujian Gutian Pharmaceutical Co., Ltd.
13.2.1 Fujian Gutian Pharmaceutical Co., Ltd. Company Information
13.2.2 Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.2.3 Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Fujian Gutian Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Fujian Gutian Pharmaceutical Co., Ltd. Latest Developments
13.3 Shijiazhuang Kangli Pharmaceutical Co., Ltd.
13.3.1 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Company Information
13.3.2 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.3.3 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Latest Developments
13.4 North China Pharmaceutical Co., Ltd.
13.4.1 North China Pharmaceutical Co., Ltd. Company Information
13.4.2 North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.4.3 North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 North China Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 North China Pharmaceutical Co., Ltd. Latest Developments
13.5 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
13.5.1 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Company Information
13.5.2 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.5.3 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Latest Developments
13.6 North China Pharmaceutical Hebei Huanuo Co., Ltd.
13.6.1 North China Pharmaceutical Hebei Huanuo Co., Ltd. Company Information
13.6.2 North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.6.3 North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 North China Pharmaceutical Hebei Huanuo Co., Ltd. Main Business Overview
13.6.5 North China Pharmaceutical Hebei Huanuo Co., Ltd. Latest Developments
13.7 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
13.7.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
13.7.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.7.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Latest Developments
13.8 Ningxia Zhouyang Pharmaceutical Co., Ltd.
13.8.1 Ningxia Zhouyang Pharmaceutical Co., Ltd. Company Information
13.8.2 Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.8.3 Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Ningxia Zhouyang Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Ningxia Zhouyang Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adenosylcobalamin Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Adenosylcobalamin Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Adenosylcobalamin Tablets by Country/Region, 2021, 2025 & 2032
2.2 Adenosylcobalamin Tablets Segment by Type
2.2.1 Boxed
2.2.2 Bottled
2.2.3 Adenosylcobalamin Tablets Sales by Type
2.2.3.1 Global Adenosylcobalamin Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Adenosylcobalamin Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Adenosylcobalamin Tablets Sale Price by Type (2021-2026)
2.3 Adenosylcobalamin Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Adenosylcobalamin Tablets Sales by Application
2.3.4.1 Global Adenosylcobalamin Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Adenosylcobalamin Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Adenosylcobalamin Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Adenosylcobalamin Tablets Breakdown Data by Company
3.1.1 Global Adenosylcobalamin Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Adenosylcobalamin Tablets Sales Market Share by Company (2021-2026)
3.2 Global Adenosylcobalamin Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Adenosylcobalamin Tablets Revenue by Company (2021-2026)
3.2.2 Global Adenosylcobalamin Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Adenosylcobalamin Tablets Sale Price by Company
3.4 Key Manufacturers Adenosylcobalamin Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adenosylcobalamin Tablets Product Location Distribution
3.4.2 Players Adenosylcobalamin Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ADENOSYLCOBALAMIN TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Adenosylcobalamin Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Adenosylcobalamin Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Adenosylcobalamin Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Adenosylcobalamin Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Adenosylcobalamin Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Adenosylcobalamin Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Adenosylcobalamin Tablets Sales Growth
4.4 APAC Adenosylcobalamin Tablets Sales Growth
4.5 Europe Adenosylcobalamin Tablets Sales Growth
4.6 Middle East & Africa Adenosylcobalamin Tablets Sales Growth
5 AMERICAS
5.1 Americas Adenosylcobalamin Tablets Sales by Country
5.1.1 Americas Adenosylcobalamin Tablets Sales by Country (2021-2026)
5.1.2 Americas Adenosylcobalamin Tablets Revenue by Country (2021-2026)
5.2 Americas Adenosylcobalamin Tablets Sales by Type (2021-2026)
5.3 Americas Adenosylcobalamin Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adenosylcobalamin Tablets Sales by Region
6.1.1 APAC Adenosylcobalamin Tablets Sales by Region (2021-2026)
6.1.2 APAC Adenosylcobalamin Tablets Revenue by Region (2021-2026)
6.2 APAC Adenosylcobalamin Tablets Sales by Type (2021-2026)
6.3 APAC Adenosylcobalamin Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Adenosylcobalamin Tablets by Country
7.1.1 Europe Adenosylcobalamin Tablets Sales by Country (2021-2026)
7.1.2 Europe Adenosylcobalamin Tablets Revenue by Country (2021-2026)
7.2 Europe Adenosylcobalamin Tablets Sales by Type (2021-2026)
7.3 Europe Adenosylcobalamin Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adenosylcobalamin Tablets by Country
8.1.1 Middle East & Africa Adenosylcobalamin Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Adenosylcobalamin Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Adenosylcobalamin Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Adenosylcobalamin Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adenosylcobalamin Tablets
10.3 Manufacturing Process Analysis of Adenosylcobalamin Tablets
10.4 Industry Chain Structure of Adenosylcobalamin Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adenosylcobalamin Tablets Distributors
11.3 Adenosylcobalamin Tablets Customer
12 WORLD FORECAST REVIEW FOR ADENOSYLCOBALAMIN TABLETS BY GEOGRAPHIC REGION
12.1 Global Adenosylcobalamin Tablets Market Size Forecast by Region
12.1.1 Global Adenosylcobalamin Tablets Forecast by Region (2027-2032)
12.1.2 Global Adenosylcobalamin Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Adenosylcobalamin Tablets Forecast by Type (2027-2032)
12.7 Global Adenosylcobalamin Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hebei Bianque Pharmaceutical Co., Ltd.
13.1.1 Hebei Bianque Pharmaceutical Co., Ltd. Company Information
13.1.2 Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.1.3 Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hebei Bianque Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Hebei Bianque Pharmaceutical Co., Ltd. Latest Developments
13.2 Fujian Gutian Pharmaceutical Co., Ltd.
13.2.1 Fujian Gutian Pharmaceutical Co., Ltd. Company Information
13.2.2 Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.2.3 Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Fujian Gutian Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Fujian Gutian Pharmaceutical Co., Ltd. Latest Developments
13.3 Shijiazhuang Kangli Pharmaceutical Co., Ltd.
13.3.1 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Company Information
13.3.2 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.3.3 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Latest Developments
13.4 North China Pharmaceutical Co., Ltd.
13.4.1 North China Pharmaceutical Co., Ltd. Company Information
13.4.2 North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.4.3 North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 North China Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 North China Pharmaceutical Co., Ltd. Latest Developments
13.5 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
13.5.1 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Company Information
13.5.2 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.5.3 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Latest Developments
13.6 North China Pharmaceutical Hebei Huanuo Co., Ltd.
13.6.1 North China Pharmaceutical Hebei Huanuo Co., Ltd. Company Information
13.6.2 North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.6.3 North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 North China Pharmaceutical Hebei Huanuo Co., Ltd. Main Business Overview
13.6.5 North China Pharmaceutical Hebei Huanuo Co., Ltd. Latest Developments
13.7 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
13.7.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
13.7.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.7.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Latest Developments
13.8 Ningxia Zhouyang Pharmaceutical Co., Ltd.
13.8.1 Ningxia Zhouyang Pharmaceutical Co., Ltd. Company Information
13.8.2 Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolios and Specifications
13.8.3 Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Ningxia Zhouyang Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Ningxia Zhouyang Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AdenosylcobalaminTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. AdenosylcobalaminTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Boxed
Table 4. Major Players of Bottled
Table 5. Global AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Table 7. Global AdenosylcobalaminTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global AdenosylcobalaminTablets Revenue Market Share by Type (2021-2026)
Table 9. Global AdenosylcobalaminTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global AdenosylcobalaminTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global AdenosylcobalaminTablets Sale Market Share by Application (2021-2026)
Table 12. Global AdenosylcobalaminTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global AdenosylcobalaminTablets Revenue Market Share by Application (2021-2026)
Table 14. Global AdenosylcobalaminTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global AdenosylcobalaminTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global AdenosylcobalaminTablets Sales Market Share by Company (2021-2026)
Table 17. Global AdenosylcobalaminTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global AdenosylcobalaminTablets Revenue Market Share by Company (2021-2026)
Table 19. Global AdenosylcobalaminTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers AdenosylcobalaminTablets Producing Area Distribution and Sales Area
Table 21. Players AdenosylcobalaminTablets Products Offered
Table 22. AdenosylcobalaminTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global AdenosylcobalaminTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global AdenosylcobalaminTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global AdenosylcobalaminTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global AdenosylcobalaminTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global AdenosylcobalaminTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global AdenosylcobalaminTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global AdenosylcobalaminTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global AdenosylcobalaminTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas AdenosylcobalaminTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas AdenosylcobalaminTablets Sales Market Share by Country (2021-2026)
Table 35. Americas AdenosylcobalaminTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas AdenosylcobalaminTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC AdenosylcobalaminTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC AdenosylcobalaminTablets Sales Market Share by Region (2021-2026)
Table 40. APAC AdenosylcobalaminTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC AdenosylcobalaminTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe AdenosylcobalaminTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe AdenosylcobalaminTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe AdenosylcobalaminTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa AdenosylcobalaminTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa AdenosylcobalaminTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa AdenosylcobalaminTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of AdenosylcobalaminTablets
Table 52. Key Market Challenges & Risks of AdenosylcobalaminTablets
Table 53. Key Industry Trends of AdenosylcobalaminTablets
Table 54. AdenosylcobalaminTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. AdenosylcobalaminTablets Distributors List
Table 57. AdenosylcobalaminTablets Customer List
Table 58. Global AdenosylcobalaminTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global AdenosylcobalaminTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas AdenosylcobalaminTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas AdenosylcobalaminTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC AdenosylcobalaminTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC AdenosylcobalaminTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe AdenosylcobalaminTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe AdenosylcobalaminTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa AdenosylcobalaminTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa AdenosylcobalaminTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global AdenosylcobalaminTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global AdenosylcobalaminTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global AdenosylcobalaminTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global AdenosylcobalaminTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Hebei Bianque Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Hebei Bianque Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 74. Hebei Bianque Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Hebei Bianque Pharmaceutical Co., Ltd. Main Business
Table 76. Hebei Bianque Pharmaceutical Co., Ltd. Latest Developments
Table 77. Fujian Gutian Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Fujian Gutian Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 79. Fujian Gutian Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Fujian Gutian Pharmaceutical Co., Ltd. Main Business
Table 81. Fujian Gutian Pharmaceutical Co., Ltd. Latest Developments
Table 82. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Shijiazhuang Kangli Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 84. Shijiazhuang Kangli Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Main Business
Table 86. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Latest Developments
Table 87. North China Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. North China Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 89. North China Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. North China Pharmaceutical Co., Ltd. Main Business
Table 91. North China Pharmaceutical Co., Ltd. Latest Developments
Table 92. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 94. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Main Business
Table 96. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Latest Developments
Table 97. North China Pharmaceutical Hebei Huanuo Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. North China Pharmaceutical Hebei Huanuo Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 99. North China Pharmaceutical Hebei Huanuo Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. North China Pharmaceutical Hebei Huanuo Co., Ltd. Main Business
Table 101. North China Pharmaceutical Hebei Huanuo Co., Ltd. Latest Developments
Table 102. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 104. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Main Business
Table 106. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Latest Developments
Table 107. Ningxia Zhouyang Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Ningxia Zhouyang Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 109. Ningxia Zhouyang Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Ningxia Zhouyang Pharmaceutical Co., Ltd. Main Business
Table 111. Ningxia Zhouyang Pharmaceutical Co., Ltd. Latest Developments
Table 1. AdenosylcobalaminTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. AdenosylcobalaminTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Boxed
Table 4. Major Players of Bottled
Table 5. Global AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Table 7. Global AdenosylcobalaminTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global AdenosylcobalaminTablets Revenue Market Share by Type (2021-2026)
Table 9. Global AdenosylcobalaminTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global AdenosylcobalaminTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global AdenosylcobalaminTablets Sale Market Share by Application (2021-2026)
Table 12. Global AdenosylcobalaminTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global AdenosylcobalaminTablets Revenue Market Share by Application (2021-2026)
Table 14. Global AdenosylcobalaminTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global AdenosylcobalaminTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global AdenosylcobalaminTablets Sales Market Share by Company (2021-2026)
Table 17. Global AdenosylcobalaminTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global AdenosylcobalaminTablets Revenue Market Share by Company (2021-2026)
Table 19. Global AdenosylcobalaminTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers AdenosylcobalaminTablets Producing Area Distribution and Sales Area
Table 21. Players AdenosylcobalaminTablets Products Offered
Table 22. AdenosylcobalaminTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global AdenosylcobalaminTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global AdenosylcobalaminTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global AdenosylcobalaminTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global AdenosylcobalaminTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global AdenosylcobalaminTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global AdenosylcobalaminTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global AdenosylcobalaminTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global AdenosylcobalaminTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas AdenosylcobalaminTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas AdenosylcobalaminTablets Sales Market Share by Country (2021-2026)
Table 35. Americas AdenosylcobalaminTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas AdenosylcobalaminTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC AdenosylcobalaminTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC AdenosylcobalaminTablets Sales Market Share by Region (2021-2026)
Table 40. APAC AdenosylcobalaminTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC AdenosylcobalaminTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe AdenosylcobalaminTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe AdenosylcobalaminTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe AdenosylcobalaminTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa AdenosylcobalaminTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa AdenosylcobalaminTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa AdenosylcobalaminTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa AdenosylcobalaminTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of AdenosylcobalaminTablets
Table 52. Key Market Challenges & Risks of AdenosylcobalaminTablets
Table 53. Key Industry Trends of AdenosylcobalaminTablets
Table 54. AdenosylcobalaminTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. AdenosylcobalaminTablets Distributors List
Table 57. AdenosylcobalaminTablets Customer List
Table 58. Global AdenosylcobalaminTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global AdenosylcobalaminTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas AdenosylcobalaminTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas AdenosylcobalaminTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC AdenosylcobalaminTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC AdenosylcobalaminTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe AdenosylcobalaminTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe AdenosylcobalaminTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa AdenosylcobalaminTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa AdenosylcobalaminTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global AdenosylcobalaminTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global AdenosylcobalaminTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global AdenosylcobalaminTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global AdenosylcobalaminTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Hebei Bianque Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Hebei Bianque Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 74. Hebei Bianque Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Hebei Bianque Pharmaceutical Co., Ltd. Main Business
Table 76. Hebei Bianque Pharmaceutical Co., Ltd. Latest Developments
Table 77. Fujian Gutian Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Fujian Gutian Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 79. Fujian Gutian Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Fujian Gutian Pharmaceutical Co., Ltd. Main Business
Table 81. Fujian Gutian Pharmaceutical Co., Ltd. Latest Developments
Table 82. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Shijiazhuang Kangli Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 84. Shijiazhuang Kangli Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Main Business
Table 86. Shijiazhuang Kangli Pharmaceutical Co., Ltd. Latest Developments
Table 87. North China Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. North China Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 89. North China Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. North China Pharmaceutical Co., Ltd. Main Business
Table 91. North China Pharmaceutical Co., Ltd. Latest Developments
Table 92. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 94. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Main Business
Table 96. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Latest Developments
Table 97. North China Pharmaceutical Hebei Huanuo Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. North China Pharmaceutical Hebei Huanuo Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 99. North China Pharmaceutical Hebei Huanuo Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. North China Pharmaceutical Hebei Huanuo Co., Ltd. Main Business
Table 101. North China Pharmaceutical Hebei Huanuo Co., Ltd. Latest Developments
Table 102. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 104. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Main Business
Table 106. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Latest Developments
Table 107. Ningxia Zhouyang Pharmaceutical Co., Ltd. Basic Information, AdenosylcobalaminTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Ningxia Zhouyang Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Product Portfolios and Specifications
Table 109. Ningxia Zhouyang Pharmaceutical Co., Ltd. AdenosylcobalaminTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Ningxia Zhouyang Pharmaceutical Co., Ltd. Main Business
Table 111. Ningxia Zhouyang Pharmaceutical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of AdenosylcobalaminTablets
Figure 2. AdenosylcobalaminTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AdenosylcobalaminTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global AdenosylcobalaminTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. AdenosylcobalaminTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. AdenosylcobalaminTablets Sales Market Share by Country/Region (2025)
Figure 10. AdenosylcobalaminTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Boxed
Figure 12. Product Picture of Bottled
Figure 13. Global AdenosylcobalaminTablets Sales Market Share by Type in 2026
Figure 14. Global AdenosylcobalaminTablets Revenue Market Share by Type (2021-2026)
Figure 15. AdenosylcobalaminTablets Consumed in Hospital
Figure 16. Global AdenosylcobalaminTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. AdenosylcobalaminTablets Consumed in Clinic
Figure 18. Global AdenosylcobalaminTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. AdenosylcobalaminTablets Consumed in Other
Figure 20. Global AdenosylcobalaminTablets Market: Other (2021-2026) & (K Units)
Figure 21. Global AdenosylcobalaminTablets Sale Market Share by Application (2025)
Figure 22. Global AdenosylcobalaminTablets Revenue Market Share by Application in 2026
Figure 23. AdenosylcobalaminTablets Sales by Company in 2026 (K Units)
Figure 24. Global AdenosylcobalaminTablets Sales Market Share by Company in 2026
Figure 25. AdenosylcobalaminTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global AdenosylcobalaminTablets Revenue Market Share by Company in 2026
Figure 27. Global AdenosylcobalaminTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global AdenosylcobalaminTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas AdenosylcobalaminTablets Sales 2021-2026 (K Units)
Figure 30. Americas AdenosylcobalaminTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC AdenosylcobalaminTablets Sales 2021-2026 (K Units)
Figure 32. APAC AdenosylcobalaminTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe AdenosylcobalaminTablets Sales 2021-2026 (K Units)
Figure 34. Europe AdenosylcobalaminTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa AdenosylcobalaminTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa AdenosylcobalaminTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas AdenosylcobalaminTablets Sales Market Share by Country in 2026
Figure 38. Americas AdenosylcobalaminTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas AdenosylcobalaminTablets Sales Market Share by Application (2021-2026)
Figure 41. United States AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC AdenosylcobalaminTablets Sales Market Share by Region in 2026
Figure 46. APAC AdenosylcobalaminTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC AdenosylcobalaminTablets Sales Market Share by Application (2021-2026)
Figure 49. China AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe AdenosylcobalaminTablets Sales Market Share by Country in 2026
Figure 57. Europe AdenosylcobalaminTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe AdenosylcobalaminTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa AdenosylcobalaminTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa AdenosylcobalaminTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of AdenosylcobalaminTablets in 2026
Figure 74. Manufacturing Process Analysis of AdenosylcobalaminTablets
Figure 75. Industry Chain Structure of AdenosylcobalaminTablets
Figure 76. Channels of Distribution
Figure 77. Global AdenosylcobalaminTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global AdenosylcobalaminTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global AdenosylcobalaminTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global AdenosylcobalaminTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global AdenosylcobalaminTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global AdenosylcobalaminTablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of AdenosylcobalaminTablets
Figure 2. AdenosylcobalaminTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AdenosylcobalaminTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global AdenosylcobalaminTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. AdenosylcobalaminTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. AdenosylcobalaminTablets Sales Market Share by Country/Region (2025)
Figure 10. AdenosylcobalaminTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Boxed
Figure 12. Product Picture of Bottled
Figure 13. Global AdenosylcobalaminTablets Sales Market Share by Type in 2026
Figure 14. Global AdenosylcobalaminTablets Revenue Market Share by Type (2021-2026)
Figure 15. AdenosylcobalaminTablets Consumed in Hospital
Figure 16. Global AdenosylcobalaminTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. AdenosylcobalaminTablets Consumed in Clinic
Figure 18. Global AdenosylcobalaminTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. AdenosylcobalaminTablets Consumed in Other
Figure 20. Global AdenosylcobalaminTablets Market: Other (2021-2026) & (K Units)
Figure 21. Global AdenosylcobalaminTablets Sale Market Share by Application (2025)
Figure 22. Global AdenosylcobalaminTablets Revenue Market Share by Application in 2026
Figure 23. AdenosylcobalaminTablets Sales by Company in 2026 (K Units)
Figure 24. Global AdenosylcobalaminTablets Sales Market Share by Company in 2026
Figure 25. AdenosylcobalaminTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global AdenosylcobalaminTablets Revenue Market Share by Company in 2026
Figure 27. Global AdenosylcobalaminTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global AdenosylcobalaminTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas AdenosylcobalaminTablets Sales 2021-2026 (K Units)
Figure 30. Americas AdenosylcobalaminTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC AdenosylcobalaminTablets Sales 2021-2026 (K Units)
Figure 32. APAC AdenosylcobalaminTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe AdenosylcobalaminTablets Sales 2021-2026 (K Units)
Figure 34. Europe AdenosylcobalaminTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa AdenosylcobalaminTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa AdenosylcobalaminTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas AdenosylcobalaminTablets Sales Market Share by Country in 2026
Figure 38. Americas AdenosylcobalaminTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas AdenosylcobalaminTablets Sales Market Share by Application (2021-2026)
Figure 41. United States AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC AdenosylcobalaminTablets Sales Market Share by Region in 2026
Figure 46. APAC AdenosylcobalaminTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC AdenosylcobalaminTablets Sales Market Share by Application (2021-2026)
Figure 49. China AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe AdenosylcobalaminTablets Sales Market Share by Country in 2026
Figure 57. Europe AdenosylcobalaminTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe AdenosylcobalaminTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa AdenosylcobalaminTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa AdenosylcobalaminTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa AdenosylcobalaminTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries AdenosylcobalaminTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of AdenosylcobalaminTablets in 2026
Figure 74. Manufacturing Process Analysis of AdenosylcobalaminTablets
Figure 75. Industry Chain Structure of AdenosylcobalaminTablets
Figure 76. Channels of Distribution
Figure 77. Global AdenosylcobalaminTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global AdenosylcobalaminTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global AdenosylcobalaminTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global AdenosylcobalaminTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global AdenosylcobalaminTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global AdenosylcobalaminTablets Revenue Market Share Forecast by Application (2027-2032)
